TGTX Next Earnings Date Notes

— TG Therapeutics (TGTX) is a biotechnology company focused on developing – and now commercializing – treatments for B-cell diseases, with its lead product BRIUMVI® (ublituximab-xiiy) approved for relapsing forms of multiple sclerosis (RMS). Investors should be keenly aware that the company's long-term success is now closely tied to the commercial launch trajectory of BRIUMVI® in the U.S. & its ability to capture market share from established MS therapies such as Ocrevus® & Kesimpta®. Key performance metrics to monitor include BRIUMVI®'s net product revenue growth, total patient/prescription trends, gross-to-net realization, and updates on payer coverage and physician adoption. Additionally, pay close attention to operating expenses, as the company transitions from a clinical-stage entity to a commercial business, and to future pipeline developments that may broaden its revenue base. The upcoming earnings call is an essential opportunity for insight into management's commercial execution, guidance, and updated expectations on market penetration, as well as longer-term strategic initiatives and regulatory milestones. The next projected earnings date for TGTX is 11/2/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

TGTX Next Earnings Date FAQ

On this page we presented the TGTX Next Earnings Date information for TG Therapeutics along with recent past earnings dates. For Q2 of 2026, TGTX reported earnings of 0.050/share, with the earnings report taking place on 8/3/2026. For Q1 of 2026, TGTX reported earnings of 0.180/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, TGTX reported earnings of 0.140/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, TGTX reported earnings of 2.430/share, with the earnings report taking place on 11/3/2025. For Q2 of 2025, TGTX reported earnings of 0.170/share, with the earnings report taking place on 8/4/2025. Based on these past earnings dates, the projected next earnings date for TGTX is 11/2/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as TG Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to TG Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research TG Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next TGTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up TGTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the TGTX next earnings date.